IL2RA Gene: Interleukin 2 Receptor Subunit Alpha

A key regulator of immune cell activation and autoimmune susceptibility

Gene Information Card

Symbol IL2RA
Full Name Interleukin 2 Receptor Subunit Alpha
Gene Type protein-coding
Chromosomal Location 10p15.1
NCBI Gene ID 3559 ncbi.nlm.nih.gov/gene/3559
Ensembl ID ENSG00000134460
UniProt ID P01589
OMIM ID 147730
HGNC ID 6008
Aliases CD25, IDDM10, IL2R, TCGFR

Description

The IL2RA gene encodes the alpha subunit of the interleukin-2 receptor (IL-2R), a high-affinity receptor for interleukin-2. This subunit, also known as CD25, is essential for T cell proliferation, activation, and immune regulation. IL2RA expression is tightly regulated and is a marker for regulatory T cells. Genetic variants in IL2RA are associated with autoimmune diseases such as type 1 diabetes and multiple sclerosis, as well as immunodeficiency syndromes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 1 Diabetes IL2RA variants alter IL-2 signaling, impairing regulatory T cell function and promoting autoimmunity OMIM 147730; NCBI Gene
Multiple Sclerosis Polymorphisms in IL2RA affect immune cell activation and susceptibility to demyelination OMIM 147730; NCBI Gene
Immunodeficiency 41 (IMD41) Loss-of-function mutations in IL2RA disrupt high-affinity IL-2 binding, leading to severe combined immunodeficiency OMIM 147730; ClinVar
Autoimmune Lymphoproliferative Syndrome (ALPS) IL2RA mutations impair apoptosis and T cell homeostasis, causing lymphoproliferation OMIM 147730; NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph Node 12.5 High
Spleen 10.8 High
Blood 8.2 Medium
Bone Marrow 6.1 Medium
Lung 2.3 Low
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T cell leukemia) 15.0 High expression of CD25
Raji (Burkitt lymphoma) 0.5 Low expression
HEK293 (embryonic kidney) 0.2 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.200C>T (p.Thr67Ile) Missense Rare Reduced IL-2 binding affinity; associated with IMD41
c.497G>A (p.Arg166Gln) Missense Rare Impaired receptor signaling; linked to autoimmunity
rs2104286 Intronic variant Common (MAF ~0.2) Risk allele for type 1 diabetes and multiple sclerosis
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in IL2RA (e.g., p.Thr67Ile) disrupt IL-2 binding and receptor signaling, leading to immunodeficiency (IMD41).

Gain of Function (GOF)

No well-characterized gain-of-function mutations are reported in IL2RA.

Dominant Negative (DN)

Dominant-negative effects have not been clearly established for IL2RA mutations.

Pathways

• IL-2 signaling pathway (Reactome: R-HSA-451927)
• JAK-STAT signaling pathway (KEGG: hsa04630)
• T cell receptor signaling pathway (KEGG: hsa04660)
• Regulation of activated T cell proliferation (Reactome: R-HSA-202430)

Protein Summary

The IL2RA protein (CD25) is a 55 kDa transmembrane glycoprotein that forms the high-affinity IL-2 receptor complex with IL2RB (CD122) and IL2RG (CD132). It is expressed on activated T cells, regulatory T cells, and some B cells. CD25 binds IL-2 with low affinity alone but increases receptor affinity when complexed. The intracellular domain is short and lacks catalytic activity; signaling is mediated through associated subunits. CD25 is a key marker for regulatory T cells and is targeted in immunotherapy for certain cancers.

Related Products

Product name Cat.No. Species Gene ID
IL2RA Knockout HEK293 Cell Line EDJ-KQ493 Human 3559 Details Get a Quote
IL2RA Knockout HeLa Cell Line EDJ-KQ53631 Human 3559 Details Get a Quote
IL2RA Knockout A-549 Cell Line EDJ-KQ62106 Human 3559 Details Get a Quote
IL2RA Knockout HCT 116 Cell Line EDJ-KQ70593 Human 3559 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: